Stocks to Buy

Identifying winning stocks requires more than scanning headlines. InvestorPlace analysts focus on long-term themes, market timing, and structural shifts shaping where capital is flowing next, highlighting stocks positioned to benefit from those trends.

It’s Okay to Be Cautious About Nio and Still Hit the Buy Button

By Chris Markoch, InvestorPlace Contributor
NIO stock looks more like a trade than an investment at this time. There are gains to be made, but Nio is too volatile to chase higher prices.

7 Struggling Chinese Stocks Set for a Turnaround in 2022

By Larry Ramer, InvestorPlace Contributor
The Chinese government seems to be becoming more benevolent towards most tech companies, paving the way for Chinese stocks to do well this year.

7 Safe Stocks to Rely On When the Market Swerves

By Louis Navellier and the InvestorPlace Research Staff
When markets that have flown so high for so long start to tumble, along with an economy that transitioning, safe stocks are essential.

Why AT&T Is a Best-of-Both-Worlds Investment

By Chris Lau, InvestorPlace Contributor
When it comes to T stock, investors get a steady dividend as mobility subscriptions grow as well as an entertainment spinoff this year.

After Alibaba’s Terrible 2021, It’s Time to Catch This Falling Knife

By Cristian Docan
After a 50% Drawdown, BABA's cheap valuation and robust growth are an opportunity for investors looking for a long play in the tech space

7 Top Growth Stocks to Add to Your Buy List Now

By Bret Kenwell, InvestorPlace Contributor
Growth stocks have been obliterated, but that doesn't mean all of them are bad businesses! Here are seven quality growth stocks worth buying.

7 Bank Stocks to Buy as Goldman Sachs Girds for 5+ Rate Hikes

By Josh Enomoto, InvestorPlace Contributor
With the Federal Reserve signaling higher interest rates and thus rising borrowing costs, these viable bank stocks may benefit.

Block Is an Outright Steal Under $100

By Will Ashworth, InvestorPlace Contributor
PayPal’s downbeat guidance for 2022 hurt the Block share price. Down 14%, SQ stock hasn’t traded under $100 since the start of the pandemic.

Novavax Stock Is a Buy After This Overdone Sell-Off

By Larry Ramer, InvestorPlace Contributor
NVAX stock dropped too sharply on a negative Reuters article about Novavax, creating a great buying opportunity for investors.

7 Tempting Sin Stocks to Profit From the Pandemic’s Most Popular Vices

By Tezcan Gecgil, InvestorPlace Contributor
After the recent market decline, investors are discovering that vices may not a bad thing to invest in. Here are 7 top sin stocks to buy now.

4 Super Bowl Stocks That Could See an Ad Bump

By Joel Baglole, InvestorPlace Contributor
Super Bowl stocks have the potential to see big gains as their companies have a major presence at this year's Super Bowl.

3 Best Bear Market Stocks to Buy Now to Prepare for a Bumpy Ride Ahead

By Joel Baglole, InvestorPlace Contributor
The turbulent times continue. "Volatility" is the watch word in stock markets these days as the gyrations seen in January continue through February earnings season.

Why Ford Motor Company Is a Buy After Earnings

By Louis Navellier, Editor, Growth Investor
The global semiconductor shortage and supply constraints took a toll on Ford's latest earnings. Nonetheless, F stock remains a buy.

Why Micron Stock Is a Definite Buy on Weakness

By Larry Ramer, InvestorPlace Contributor
MU stock has multiple, strong, positive catalysts, and analysts are very upbeat on MU stock, whose valuation is very attractive.

4 Top Stock Trades for Wednesday: PTON, TDOC, PFE, FB

By Bret Kenwell, InvestorPlace Contributor
Peloton, Pfizer, Teladoc and Meta were our top stock trades for Wednesday. Now, let's have a look at how the charts are setting up.

The Take-Two Deal Is a Game Changer for Zynga Investors

By David Moadel, InvestorPlace Contributor
As two established tech businesses combine their intellectual property, ZNGA stock should be ready to reclaim its 2021 peak price point.

Take a Leap Into Novavax Stock After Vaccine Sales Start

By Chris Lau, InvestorPlace Contributor
Novavax is worth speculating on at current levels. NVAX stock has fallen below the $100 mark ahead of its global Covid-19 vaccine launch.

Be Opportunistic in the Era of Streaming with Roku

By David Moadel, InvestorPlace Contributor
The research suggests that the next decade will be dominated by content streaming, and you can capture the potential profits with ROKU stock.

Opendoor Technologies Needs Time to Recover

By Tezcan Gecgil, InvestorPlace Contributor
The recent decline in OPEN stock could mean a long-term opportunity for patient investors.
Load More Articles